Hyponatremia in multiple myeloma is –
**Core Concept**
In multiple myeloma, hyponatremia occurs due to the inappropriate secretion of antidiuretic hormone (SIADH) or other mechanisms that affect sodium levels. This is a result of the complex interplay between various factors, including the tumor itself, hormonal imbalances, and the body's response to the disease.
**Why the Correct Answer is Right**
Hyponatremia in multiple myeloma is often pseudo or SIADH-induced, caused by the release of ADH-like substances by the tumor cells, leading to excessive water retention and subsequent dilution of sodium levels. This is distinct from absolute hyponatremia, which would be caused by a true deficiency of sodium. The pseudo or SIADH-induced hyponatremia is a result of the tumor's impact on the body's hormonal balance and renal function.
**Why Each Wrong Option is Incorrect**
**Option A:** True hyponatremia would involve a decrease in sodium levels due to a genuine deficiency, which is not the primary mechanism in multiple myeloma.
**Option B:** Relative hyponatremia refers to a decrease in sodium levels in the context of other electrolyte imbalances, which is not the primary concern in multiple myeloma.
**Option C:** Absolute hyponatremia would involve a true deficiency of sodium, which is not the primary mechanism in multiple myeloma.
**Clinical Pearl / High-Yield Fact**
In multiple myeloma, SIADH-induced hyponatremia can be challenging to manage, and it's essential to consider the underlying pathophysiology when developing treatment plans to avoid exacerbating the condition. This involves careful monitoring of sodium levels, fluid balance, and renal function.
**Correct Answer:**
β Correct Answer: D. Pseudo.